Table 4. Distribution of T3SS virulotypes according to antimicrobial susceptibility of P. aeruginosa isolates.
|
exoS+/exoU+ n = 30 |
exoS+
/exoU- n = 24 |
P-value* | |
|---|---|---|---|
| Antimicrobial resistance | |||
| FEP | 15 | 12 | 1.000 |
| IMP | 21 | 15 | 0.5770 |
| MER | 15 | 11 | 0.7905 |
| TZP | 9 | 8 | 1.000 |
| GN | 13 | 11 | 1.000 |
| CIP | 14 | 13 | 0.7846 |
| Susceptibility phenotype | |||
| MultiS | 3 | 6 | 0.2702 |
| ModR | 15 | 8 | 0.2738 |
| MDR | 5 | 1 | 0.2100 |
| XDR | 7 | 9 | 0.3695 |
| MDR+XDR | 12 | 10 | 1.000 |
FEP, cefepime; IMP, imipenem; MER, meropenem; TZP, piperacillin+tazobactam; GN, gentamicin; CIP, ciprofloxacin; POL, polymyxin B; MultiS, susceptible to all tested antibiotics; ModR, moderately resistant; MDR, multi-drug resistant; XDR, extensively drug-resistant.
* P values were calculated using the Fisher’s exact test.